Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Adlai Nortye Ltd.
ANL | US
8.02
USD0.04
0.50%
ANL | US
Loading StockChartView...
About Adlai Nortye Ltd.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
17/03/2026
Close
8.02
Open
7.54
High
8.12
Low
7.54
View Less
ANL | US
Risk
77.7
Sharpe
1.75
Luna's Score
49/100
Recommendation
Hold
Luna says (ANL | US)
What's Working
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
71.5%1 month
77.7%3 months
241.3%6 months
184.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.35
Debt to equity
0.73
Debt to assets
0.36
Ent. to EBITDA
-
Ent. to rev.
2.70
PEG
-
Other Fundamentals
EBITDA
-63.57M
MarketCap
295.94M
MarketCap(USD)
295.94M
Div. yield
-
Op. margin
-1.29K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
0.72
Short perc.
0.03
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.58
Range1M
2.94
Range3M
10.92
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.64
Price X volume
1.15M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | 2.70 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.35 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 241.27 | 72.80 | Riskier |
| Debt to Equity | 0.73 | -1.23 | Expensive |
| Debt to Assets | 0.36 | 0.25 | Expensive |
| Market Cap | 295.94M | 3.66B | Emerging |
